InterventionsHuman trial
Efficacy and Safety of a Novel Oral Small Molecule GLP-1 Receptor Agonist HDM1002 in Chinese Overweight and Obese Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
ADA Scientific Sessions 2026 Abstract
The paper
LI X, ZHAO L, LU Y et al.
ADA Scientific Sessions 2026 Abstract · 5 Jun 2026
Presented at ADA Scientific Sessions 2026 · Poster 2609-P